Interleukin-2 (IL-2) mediates cell cycle progression and antiapoptosis in human T cells via several signal transduction pathways. The Tax protein of the human T-cell leukemia virus type I (HTLV-1) deregulates cell growth and alters the role of IL-2 in infected cells. However, Tax-immortalized cells stay dependent on IL-2, suggesting that events besides HTLV-1 gene expression are required for leukemia to develop. Here, IL-2-dependent and -independent events were analysed in a human T cell line immortalized by Tax. These studies show that, of the signaling pathways evaluated, only STAT5 remains dependent. Microarray analyses revealed several genes, including il-5, il-9 and il-13, are uniquely upregulated by IL-2 in the presence of Tax. Bioinformatics and supporting molecular biology show that some of these genes are STAT5 targets, explaining their IL-2 upregulation. These results suggest that IL-2 and viral proteins work together to induce gene expression, promoting the hypothesis that deregulation via the constitutive activation of STAT5 may lead to the IL-2-independent phenotype of HTLV-1-transformed cells.
Introduction
Interleukin-2 (IL-2), the major T-cell growth factor, is required for development of an effective immune response. As a mediator of T-cell clonal expansion and differentiation, IL-2 induces cell proliferation and antiapoptosis (Robb, 1984; Smith, 1984) . Upon IL-2/ IL-2R ligation, a variety of protein tyrosine kinases associate with the IL-2R, resulting in phosphorylation of the receptor and activation of a complex network of signaling cascades, including the Ras/MEK/ERK, PI3K, and JAK/STAT pathways (Kirken et al., 1993 (Kirken et al., , 1994 Miyazaki et al., 1994; Russell et al., 1994; Witthuhn et al., 1994) . Activation of these pathways ultimately leads to gene expression which results in the biological events observed following IL-2 stimulation. Interestingly, IL-2 regulation of these and other signaling cascades can be altered by infection of T cells with human T-cell leukemia virus type I (HTLV-1).
HTLV-1 is a human retrovirus that infects activated CD4 þ T cells and deregulates their growth, activity, and death (Hollsberg and Hafler, 1993; Hollsberg, 1999) . This virus causes an aggressive malignancy of T cells, adult T-cell leukemia (ATL) (Poiesz et al., 1980) , in a small percentage of infected individuals. The deregulation of activated CD4 þ T-cell populations is thought to be a crucial step in the loss of growth control that occurs in leukemia and is signified by the loss of dependence on IL-2. The development of IL-2 independence in HTLV-1-infected cells may be related to the subversion of IL-2-regulated signal transduction pathways and gene expression. In HTLV-1-infected, IL-2-independent cells, constitutive activation of STAT3 and STAT5, the predominant STAT family members activated by IL-2 (Darnell, 1997; O'Shea, 1997; Lin and Leonard, 2000) , as well as their respective upstream kinases, JAK1 and JAK3, is observed (Migone et al., 1995; Xu et al., 1995) . Since constitutive activation of the JAK/STAT pathway has not been observed in newly infected IL-2-dependent cells (Migone et al., 1995) , it has been hypothesized that this activation may correlate with transformation (Takemoto et al., 1997) . Other IL-2-responsive signaling pathways may be deregulated in the presence of the virus and thus also involved in the transformation process. Despite these observations, the exact mechanism of HTLV-1 transformation remains to be discovered.
Previous studies have demonstrated that many, but not all, effects of this virus on infected human T cells are mediated by the viral transactivator protein Tax (Sodroski, 1992; Yoshida, 1994; Gatza et al., 2003) . Although prior reports have established that Tax is essential for T lymphocyte immortalization, other viral proteins have been shown to be dispensable in vitro (Robek et al., 1998; Ye et al., 2003) . In addition, Tax has been demonstrated to deregulate cellular signal transduction and gene expression, as well as cell cycle progression, in cells immortalized by the protein (Hollsberg, 1999) . However, it is notable that cells immortalized by the Tax oncoprotein remain dependent on IL-2 for long-term growth in culture (Grassmann et al., 1989 (Grassmann et al., , 1992 Akagi and Shimotohno, 1993) , illustrating that Tax alone is insufficient for transformation to IL-2 independence. Other events, such as the deregulation of cellular signaling pathways and transcription factors, must be involved in order for HTLV-1 to produce the IL-2-independent phenotype characteristic of ATL cells.
To better understand the activity of IL-2 in the presence of Tax, IL-2-dependent signal transduction and gene expression were analysed in a previously described (Grassmann et al., 1989) human T cell line immortalized by the HTLV-1 pX-region. The data presented demonstrate that the PI3K targets ERK and p70
S6kinase (Gaffen, 2001 ) are constitutively active in this cell line and that the PI3K inhibitor, LY29004, blocks cell cycle progression in cells deprived of IL-2, strongly suggesting that PI3K activity is constitutive in this Taximmortalized cell line. In contrast, STAT5 activation remains IL-2 dependent, thereby indicating that STAT5-regulated transcription may be involved in maintaining the growth factor-dependent phenotype of these cells. Microarray analyses revealed that there is unique gene expression upregulated by IL-2 in the Taximmortalized line and that some of these genes encode the cytokines il-5, il-9, and il-13. Further analyses showed that STAT5 may contribute to the activation of at least some of these cytokine genes. Together, these observations allow us to conclude that IL-2 and HTLV-1 pX-region proteins such as Tax can work together to promote gene expression in immortalized, nontransformed T cells, supporting the hypothesis that deregulation of IL-2-dependent events may contribute to the transformation of HTLV-1-infected cells.
Results
The T1 cell line is dependent on IL-2 for long-term growth in culture
The Tax-immortalized T cell line, T1, was derived from infection of primary human thymocytes with a Herpesvirus saimiri vector encoding the HTLV-1 pX-region, as previously described (Grassmann et al., 1989) . Analysis of the growth characteristics of T1 cells in the absence of IL-2 demonstrated that these cells maintain good viability throughout the first 5 days of culture without IL-2; it is not until later that the cell numbers rapidly decrease ( Figure 1a ). Consistent with this observation, more cells were synchronized in the G 0/1 phase of the cell cycle the longer they were deprived of IL-2, as demonstrated by FACS analysis of DNA content (Figure 1b) . After only 1 day of IL-2 deprivation, approximately 34% of the cells were still cycling; however, this number was reduced to approximately 12% after 9 days without IL-2. In addition, a gradual and reproducible increase in apoptosis was observed (Figure 1b) . Collectively, these results clearly show that the T1 cell line is dependent on IL-2 for long-term growth.
The activation of the Ras/ERK pathway is constitutive in the T1 cell line
To determine if the Ras/ERK signaling pathway is regulated by IL-2 in T1, ERK activation was evaluated using Western blot analysis with antisera specific for phosphorylated p44/ERK1 and p42/ERK2. ERK remained phosphorylated in T1 cells even after 7 days of IL-2 deprivation (Figure 2a) . Restimulation of the cells with IL-2 after 3 days of deprivation, a time point which demonstrated approximately 100% viability of the cells (Figure 1 ), did not enhance ERK phosphorylation. These results indicate that the Ras/ERK pathway is constitutively active in this Tax-immortalized cell line.
T1 cells exhibit constitutive PI3K activation
ERK's constitutive activation in T1 indicates that upstream regulators of the kinase may also be deregulated. Previous studies have shown that optimal MEK activation by IL-2 is PI3K-dependent (Karnitz et al., 1995; Fung et al., 2003) . To further assess whether PI3K is constitutively active in T1, another downstream target of PI3K, p70
S6kinase
, was similarly analysed. Like ERK, phosphorylated p70
S6kinase was detected in T1 cells following 7 days of IL-2 withdrawal (Figure 2b ). Furthermore, IL-2 restimulation of the cells after 3 days of deprivation did not increase the amount of phosphorylated p70
S6kinase detected, thereby indicating that activation of this enzyme is no longer regulated by IL-2 in the T1 cell line. (The apparent reduction in phosphorylated p70
S6kinase at the 5 min time point was not reproducible.) To evaluate the activity of PI3K itself, the growth of IL-2-deprived T1 cells in the presence and absence of LY294002, a specific inhibitor of PI3K, was evaluated. FACS analysis of DNA content in these cells is depicted in Figure 2c . As shown, the number of S-phase cells decreases more rapidly in the presence of the PI3K inhibitor than in its absence. The effect of LY294002 was statistically significant and most dramatic at days 3 and 5, while the percentage of S-phase cells was equivalent in the two cultures after 7 days of IL-2-deprivation. Furthermore, the level of p70
S6kinase phosphorylation was reduced in cells treated with the PI3K inhibitor (Figure 2d ). Collectively, these data imply that the constitutive activation observed for PI3K is at least partly responsible for the prolonged growth and survival of T1 in the absence of IL-2.
IL-2 induces activation of STAT5 in the T1 cell line
Previous studies have demonstrated constitutive activation of the JAK/STAT pathway in HTLV-1-transformed cells (Migone et al., 1995; Xu et al., 1995) . Thus, to determine whether IL-2 regulates STAT activity in T1 cells, phosphorylation of STAT3 and STAT5 was analysed by Western blot. Tyrosine and serine phosphorylation of the STATs were examined since both events are required for maximal transcriptional activity (Decker and Kovarik, 2000) .
As shown in Figure 3a , tyrosine phosphorylation of STAT3 was essentially undetectable in the T1 cell line at any time point during IL-2 deprivation. Moreover, restimulation of the cells did not induce tyrosine phosphorylation. (The band that might represent STAT3 tyrosine phosphorylation at the 0 time point was not reproducible.) In contrast, serine phosphorylation was found to be constitutive as it was detected even after 7 days of IL-2 deprivation ( Figure 3b ) and restimulation of the cells did not increase this activity. Since STAT tyrosine phosphorylation is required for dimerization and nuclear translocation, these data suggest that STAT3 does not contribute to gene expression in T1. Constitutive STAT3 serine phosphorylation is also consistent with the constitutive activation of ERK in T1 as it phosphorylates STAT3 (Ng and Cantrell, 1997; Fung et al., 2003) .
Unlike STAT3, STAT5 activation is regulated by IL-2 in T1 (Figure 3c ). Tyrosine phosphorylation, not detected throughout the deprivation period, was observed within 5 min of IL-2 restimulation. In addition, cells grown in the presence of IL-2 (day 0 of IL-2 deprivation) consistently displayed STAT5 tyrosine phosphorylation, further supporting the conclusion that this transcription factor is IL-2-regulated in these cells. Interestingly, STAT5 serine phosphorylation ( Figure 3d ) does not appear to be regulated by IL-2. Examination of both STAT5a and STAT5b produced identical results. Collectively, the data suggest that, in the presence of IL-2, STAT5 should be optimally active and capable of promoting gene expression in these cells. S6kinase using specific antisera. TBCs were used as positive controls, as described in the Materials and methods. To control for protein loading, blots were stripped and reprobed with antisera specific for total ERK or p70
S6kinase
. The data shown are representative of at least three independent experiments. (c) T1 cells were deprived and grown in the presence or absence of LY294002 for up to 7 days followed by measurement of DNA content through FACS analysis of propidium iodide-stained cells. The results shown are representative of four independent experiments. (d) T1 cells were treated as in (c) and assessment of p70 S6kinase phosphorylation using specific antisera was done. The results shown are representative of two independent experiments IL-2-induced gene expression in Tax-immortalized T cells MM Fung et al
IL-2 upregulates gene expression in T1 that is not upregulated in primary T cells
To evaluate the levels of gene expression regulated by IL-2 in T1 cells, microarray analyses were performed. T1 cells were washed extensively and deprived of IL-2 for 3 days prior to a 0, 1-, 4-, or 8-h restimulation. The 3-day deprivation time point used in these studies was chosen for several reasons, namely high cell viability (Figure 1 ), lack of STAT5 tyrosine phosphorylation (Figure 3c ), and the ability of cells to respond to IL-2 restimulation, as proved by STAT5 activation (Figure 3c ). This experiment was performed in duplicate and total RNA was isolated at each time point. The microarray data were analysed by the Affymetrix Microarray Software Suite, version 5.1 and DNA-Chip analyzer (dChip) (Li and Wong, 2001a; Li and Wong, 2001b) . Both programs were separately utilized in order to increase the reliability of the resultant data as only those genes that yielded from both analyses were considered.
A total of 23 genes were found to be reproducibly upregulated by IL-2 at least twofold in T1, illustrating that this growth factor regulates a significant level of gene expression in these cells (Table 1) . These genes include several known IL-2-induced genes such as cyclin D2, IL-2Ra, c-myc, and lymphotoxin alpha (Lu et al., 1998; Lord et al., 2000; Kim et al., 2001; Martino et al., 2001) . Since the growth characteristics of Tax-immortalized cells differ from those of normal cells, the ability of IL-2 to induce expression of genes not normally upregulated in primary human T cells was also investigated. To accomplish this, genes upregulated by IL-2 at least twofold in T1 cells and primary human T cells were compared. As a result, of the 23 genes found to be upregulated by IL-2 in T1, 12 were discovered to be unique to this cell line (Table 1) . It was particularly striking that several of these genes were cytokines and chemokines, as well as receptors for this type of effector. Of specific interest is the unique IL-2 induction of interleukin-5, interleukin-9, and interleukin-13 in the Tax-immortalized cells. These genes have previously been reported to be expressed in IL-2-dependent, HTLV-1-immortalized cells (Chung et al., 2003) . Therefore, these genes were selected for further investigation. Verification that these cytokines are IL-2-regulated in T1 cells but not primary T cells was conducted using quantitative real-time PCR. As shown in Table 2 , expression of il-5, il-9, and il-13 was upregulated by IL-2 in the Tax-immortalized line but was either undetectable or not appreciably upregulated in primary human T cells. Not only do these data confirm that il-5, il-9 and il-13 are unique to T1 but also provide support for the microarray analyses presented here.
Genes uniquely regulated by IL-2 in T1 are targets of STAT5
To confirm the hypothesis that IL-2-regulated gene expression in T1 may be controlled by STAT5, the upstream sequence of each gene was analysed for the presence of a consensus STAT5-binding site. These analyses were limited to the identification of a consensus STAT5 binding site within 5000 bp of the translational start site of each gene. The upstream sequences were retrieved from the University of California, Santa Cruz Human Genome Browser (May 2004 assembly available at genome.ucsc.edu). In order to adequately describe the STAT5 binding site, an alignment matrix was generated using the make-matrix program of the Consensus software suite (Hertz et al., 1990; Hertz and Stormo, 1999) . The use of such a matrix is beneficial over a single consensus sequence because variations in nucleotides at positions within experimentally confirmed binding sites were considered. This generalized STAT5 alignment matrix was constructed based on sequences published by Soldaini et al. (2000) and thus represents 78 STAT5 binding site sequences (Figure 4) . The matrix cannot distinguish between isoforms and, as evidenced in Figure 4 , strongly favors the classic palindromic g-interferon-activated sequence (GAS) motif TTCNNN GAA, characteristic of STAT5a and STAT5b. This STAT5 alignment matrix was subsequently used to analyse the upstream sequence of each gene listed in Table 1 with a program called patser, which is also part of the Consensus suite. Of the 23 genes found to be upregulated by IL-2 in T1, 16 contained putative STAT5 binding sites (Table 3) . Interestingly, nine out of the 12 unique genes possess a consensus binding site for this factor. While these analyses do not attempt to identify every possible consensus STAT5 binding site in these genes and are restricted to identifying the classic GAS motif of STAT5, they identified such known STAT5 targets as cyclin D2, IL-2Ra, c-myc, SOCS2, and These values were derived from dChip analysis of the microarray data. The Affymetrix signal log ratios were similar to these with the exception of il-9, which reported a 33-fold and 56-fold increase at the 4 and 8 h time points, respectively. b The maximum fold upregulation for each gene is indicated in bold (Lu et al., 1998; Lord et al., 2000; Kim et al., 2001; Martino et al., 2001; Boer et al., 2002) . More importantly, this examination revealed that il-5, il-9, and il-13 possess consensus STAT5 binding sites within the region assessed (Table 3) . To determine if these cytokine genes are actual targets of STAT5, chromatin immunoprecipitation (Chip) was performed. As shown in Figure 5 , the il-5 and il-9 promoter sequences bind STAT5 in vivo despite the fact that neither of these genes has previously been demonstrated to be a STAT5 target. The cyclin D2 and betaactin promoters were assayed as positive and negative controls, respectively. The binding of STAT5 is observed only after IL-2 restimulation, and not in the absence of IL-2, which demonstrates once again that the activity of STAT5 is controlled by IL-2 in these cells. A successful Chip assay on the il-13 promoter proved problematic with multiple primer pairs and whether the il-13 promoter sequence is a STAT5 target remains undetermined. Still, the data presented on il-5 and il-9 verify that STAT5 binds to the regulatory regions of these genes, explaining the upregulation of these genes after IL-2 stimulation. Altogether, these results imply that STAT5, but not PI3K, regulates a significant level of IL-2-dependent gene expression in these cells.
Discussion
The observation that T cell lines expressing the Tax protein in the absence of other HTLV-1 products remain IL-2-dependent for long-term growth in culture strongly suggests that Tax is insufficient for the transformation that occurs in leukemia development. It is logical to hypothesize that the pathways regulated by IL-2 in Tax-immortalized cells may contribute to the development of leukemia. Previous studies on IL-2 stimulation of murine and human T cell lines and primary cells have suggested that three major pathways Figure 4 The STAT5 alignment matrix favors the classic GAS motif. The generalized STAT5 alignment matrix was constructed using the make-matrix program of the Consensus software suite by combining the 33 STAT5a and 45 STAT5b binding site sequences reported by Soldaini et al. (2000) Cyclin D2 IL-9 IL-5 β-actin
Figure 5 STAT5 binds the promoters of il-5 and il-9. ChIP using STAT5-specific antibodies was performed on T1 cells that were either restimulated with IL-2 for 2 h or left unstimulated following a 3-day deprivation. These results are representative of two independent experiments IL-2-induced gene expression in Tax-immortalized T cells MM Fung et al activated by IL-2 include the Ras/ERK, PI3K, and JAK/STAT pathways (Lin and Gaffen, 2001) . As demonstrated in this report, of these pathways, only STAT5 remains controlled by IL-2 in a Taximmortalized human T cell line. Deregulation of the PI3K and Ras/ERK pathways in Tax-immortalized cells has not been previously demonstrated in HTLV-1-transformed cells, but prior studies have suggested that Tax may deregulate upstream events such as PI3K and/ or Ras dependent signaling events in activation of the JNK MAPK pathway (Jin et al., 1997; Hollsberg, 1999) . Further investigation is required to determine if the PI3K and Ras/ERK pathways are constitutively active in HTLV-1-infected, nontransformed cells. If so, these observations could help to explain the unusual growth characteristics of HTLV-1-infected T cells that have not been transformed by the virus. The inability of Tax to induce IL-2-independent growth in human T cells may be partially due to the fact that it cannot directly deregulate the STAT proteins (Migone et al., 1995; Xu et al., 1995) . As demonstrated here, STAT5 activation appears to be directly responsible for a significant level of gene expression in IL-2-stimulated T1 cells. Interestingly, some of the STAT5-regulated genes are uniquely expressed in T1 cells and not in primary human T cells. These data strongly suggest that, in the presence of HTLV-1 pX-region proteins, STAT5 can upregulate expression of genes that cannot be activated under normal circumstances. While il-5 (Yamagata et al., 1997; Blumenthal et al., 1999; Li-Weber et al., 2001) , il-9 (Kelleher et al., 1991) , and il-13 (Waldele et al., 2004) have all been described to be transactivated by Tax, the studies presented here suggest that STAT5 is also required for expression of these genes. This leads to the postulate that neither Tax nor IL-2 alone is sufficient to drive expression of the genes, but Tax and IL-2 together, or Tax and the deregulation of STAT5 seen in ATL, are sufficient to direct gene expression that may ultimately contribute to the transformed phenotype of the cells.
It is particularly interesting that IL-2 promotes the expression of cytokines that have been shown to be produced by HTLV-1-infected and -transformed cells and that have been postulated to promote their growth or to influence clinical progression of the disease. For instance, eosinophilia is seen in a significant percentage of patients with ATL (Murata et al., 1992) and IL-5 has been proposed to be involved in this phenotype in at least some cases (Yamagata et al., 1997; Ogata et al., 1998) . IL-9 has been shown to be a growth factor for murine and human T cells (Uyttenhove et al., 1988; Houssiau et al., 1993) and it is produced by many HTLV-1-infected cell lines (Matsushita et al., 1997; Chung et al., 2003) . In addition, previous studies have suggested that IL-13 is a growth factor in Hodgkin's lymphoma (Skinnider et al., 2001; Skinnider et al., 2002) and the observation that IL-13 is produced by HTLV-1-infected cells (Ruckes et al., 2001; Chung et al., 2003; Waldele et al., 2004) has led to the hypothesis that IL-13 might contribute to the growth of ATL cells. In the studies by Chung et al. (2003) , IL-13 production was not correlated with the presence of IL-2 but the upregulation of this gene by IL-2 was not rigorously tested. In the studies by Waldele et al. (2004) , the IL-2-dependent cell lines were maintained in IL-2 throughout the studies performed and, therefore, the possibility exists that in HTLV-1-infected, nontransformed cells, IL-13 production is controlled by IL-2.
The studies presented here demonstrate that not all pathways normally controlled by IL-2 in primary human T cells remain regulated by the growth factor in Taximmortalized cells. However, IL-2 still regulates significant gene expression in the cells, some of which is unique. These studies suggest that STAT5 activation in the presence of HTLV-1 pX-region proteins, namely Tax but possibly others as well (Albrecht and Lairmore, 2002) , can promote the expression of genes not normally regulated by IL-2 alone. Together these observations lead to the hypothesis that IL-2 can contribute to the growth characteristics of HTLV-1-infected cells by inducing the STAT5 activation required for specific gene expression. Deregulation of this gene expression may then participate in the transformation that leads to the development of ATL. Further studies must be carried out before this interesting hypothesis can be confirmed.
Materials and methods

Cell culture and FACS analysis
The T1 cell line, immortalized with the HTLV-1 pX-region and denoted Thy-1, has been previously described (Grassmann et al., 1989) . The IL-2-dependent T1 cell line was maintained in culture at 1-2.5 Â 10 5 cells/ml in RPMI 1640 medium containing 10% FBS, L-glutamine, and 10 Cetus units/ml IL-2 (generously provided by Chiron Corp., Emeryville, CA, USA). Primary human T cells, called thymic blast cells (TBCs), were isolated from human thymus tissue, then stimulated and grown in IL-2, as previously described (Rohwer et al., 1996; Iacobelli et al., 1999; Fung et al., 2003) . Deprivation and restimulation conditions, as well as cell cycle analysis using propidium iodide staining and FACS analysis, have been previously described Fung et al., 2003) .
Western blot analysis and immunoprecipitation
T1 cells were grown and deprived of IL-2 for the times indicated. At 3 days postdeprivation, T1 cells were washed, resuspended in fresh media, and restimulated with IL-2 for the times indicated. TBCs were deprived of IL-2 for 24 h and restimulated as indicated. Western analysis was carried out as previously described (Fung et al., 2003) . STAT3 and STAT5a were immunoprecipitated using specific rabbit polyclonal antisera as per the manufacturer's protocols from 2 Â 10 7 cells lysed in NP-40 buffer (137 mM NaCl, 20 mM TRIS base, pH 7.4, 1% NP-40, 10% glycerol). Immunoprecipitates were run on SDS-PAGE for subsequent Western blot analysis.
RNA extraction and microarray analysis
RNA was isolated from two independent preparations of T1 cells that were deprived of IL-2 for 3 days and restimulated with IL-2 for 0, 1, 4, or 8 h. RNA was also isolated from two independent preparations of TBCs similarly restimulated following a 24-h deprivation. Total cellular RNA was harvested and purified using the RNeasy mini kit (Qiagen, Valencia, CA, USA) according to the manufacturer's protocol. Microarray analysis was performed by the GeneChip Core Facility of the UCSD Comprehensive Cancer Center using Affymetrix HU133A gene chips (Santa Clara, CA, USA), which contain sequences representing 14 500 known human cDNAs. cDNA labeling and hybridization was carried out according to Affymetrix protocols (available at www.affymetrix.com). Hybridized arrays were scanned by a confocal scanner and the fluorescence intensities were globally scaled to a mean intensity of 1500 using the Affymetrix Microarray Software Suite, version 5.1.
Microarray data analyses
Microarray data from the duplicate experiments were analysed using Affymetrix Microarray Software Suite, version 5.1 and DNA-Chip (dChip) analyzer software (available at www.dchip.org). The Affymetrix 5.1 software was utilized using the manufacturer's recommendations. Within dChip, the raw gene chip images were normalized, model-based expression values calculated, and samples compared. dChip developers' recommendations were used to produce a list of genes whose differential expression was at least twofold and filtered by the calculated lower 90% confidence bound. The resultant modelbased expression values for each gene at each time point are listed as 'fluorescence intensity' in Table 1 . The Consensus software suite, including make-matrix and patser, was used to create the STAT5 alignment matrix and can be obtained from bifrost.wustl.edu/consensus. The significant P-value threshold was set based on the information content, I seq , of the alignment matrix. P ¼ e ÀIseq represents the maximum frequency with which any given sequence is expected to occur in a set of random sequences (Hertz et al., 1990; Hertz and Stormo, 1999) .
Real-time PCR
Total RNA (5 mg) isolated from T1 and primary human T cells was used for cDNA synthesis by the Reverse Transcription System (Promega, Madison, WI, USA) according to the manufacturer's instructions. The level of transcript in each sample was measured by real-time PCR. All PCR amplification mixtures (25 ml) contained template cDNA, 250 ng each of forward and reverse primers, and 1 Â iQ SYBR Green SuperMix (BioRad Laboratories, Hercules, CA, USA). The reactions were performed using an Opticon detector (MJ Research, Reno, NV, USA). Opticon Monitor software, version 1.07 (MJ Research, Reno, NV, USA) enabled quantitative analysis of the PCR. A linear calibration curve for each gene was constructed from serial 10-fold dilutions of cDNA by plotting the crossing point for each dilution. The C(t) values were then calculated using this linear regression curve. The Pfaffl method (Pfaffl, 2001 ) was subsequently used to calculate fold differences. L32 was used as the reference gene to control for sample loading. 
ChIP
With the exception of preparing nuclear extracts, the ChIP assays were performed according to the Farnham lab protocol (Weinmann et al., 2001) . Briefly, 2 Â 10 7 T1 cells were grown, deprived of IL-2 for 3 days, split into two and one sample was restimulated with IL-2 for 2 h. Nuclear extracts were prepared as previously described (McGuire and Iacobelli, 1997) and protein A sepharose beads (Sigma-Aldrich, St Louis, MO, USA) were used instead of Staph cells. All PCRs were performed using 2 ml DNA from a 30 ml preparation, 500 ng each of forward and reverse primers, and Taq polymerase (Takara, Madison, WI, USA) according to the manufacturer's protocol. PCR products were visualized on 0.8% agarose gels.
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